Global Clinical Engineering Status: Post-COVID19 Review
Main Article Content
Keywords
COVID 19, Clinical Engineer, Technologist, Devices, Patient, Outcomes, Engineering, Global
Abstract
Many colleagues have written about the global reliance on health technologies whose innovation, deployment and support
continue to improve worldwide healthcare and its delivery. The World Health Organization’s-WHO 2007 Resolution WHA60.29
called for the effective use of health technologies (HT), in particular medical devices, through proper planning, assessment,
acquisition and management.
The community of professional clinical engineering (CE) practitioners’ pre-COVID19 stories are captured in the Global Clinical
Engineering Journal. An article from 2022 shows the reasons for the increased contributions of this community especially during
the pandemic in The Growing Role of Clinical Engineering: Merging Technology at the Point of Care.
This article will answer questions such as to how this global reliance was demonstrated during the COVID19 period. How the
status of the Clinical/Biomedical Engineering (CE/BME) profession that serves at the point of care changed as the world emerges
from the huge stresses of the pandemic. The article reviews the evolution of the CE profession since 2020, how it partnered
with WHO between 2020-2022 and what lessons were learned in the process. It reports future CE priorities to improve country,
regional, and global practice in 2023 and beyond. This timely preliminary report shares important findings related to patient
care support services.
Downloads
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
Author(s) must obtain all parties consent [co-author(s), others if applicable] and submit the acceptance of Copyright Agreement with their paper. Written permission must be obtained by the author for material that has been published in copyrighted material; this includes tables, figures, and quoted text that exceeds 150 words. A copy of all permissions must accompany the manuscript when published in copyrighted material. The author(s) hereby represents and warrants that the paper is original and that he/she is the author of the paper, except for material that is clearly identified as to its original source, with permission notices from the copyright owners where required. Author(s) must clearly indicate that approval for publication has been received in cases of institutional ownership.
In all submitted material authors retain all copyrights; however, the GlobalCE Journal reserve the right to reprint all or portions of the article and to post all or part of the article online. GlobalCE Journal reserves the right to edit manuscripts as required to publish in the journal. Authors are responsible for obtaining any and all clearances as appropriate. Unless stated otherwise, all articles are open-access and distributed under the terms of the Creative Commons Attribution License (CC BY 4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original author(s) and original work (e.g. first published in the Global Clinical Engineering Journal) is properly cited with the original URL and bibliographic citation information. The complete bibliographic information, a link to the original publication on www.Globalce.org well as the copyright and license information must be included. No use, distribution or reproduction is permitted which does not comply with these terms.
